Tuesday, May 21, 2019 11:26:41 AM
Experts Predict End to Decades-Long Deadlock in Drug Developments
A UC San Francisco-led consortium has received a $26.2 million award from the U.S. Army Medical Materiel Development Activity to develop treatments for traumatic brain injury. The Transforming Research and Clinical Knowledge in Traumatic Brain Injury Network, known as TRACK-TBI NET, will lead clinical trials of phase II drugs tested nationwide in 18 hospitals with Level 1 trauma centers.
“Over the course of decades, there have been more than 30 clinical trials for TBI, but to date no effective drugs have been identified,” said Geoffrey Manley, MD, PhD, principal investigator of TRACK-TBI and professor of neurosurgery in the UCSF Department of Neurological Surgery. “We hope that the new research will prove more fruitful than previous TBI studies that failed to distinguish patients by objective findings obtained from imaging or blood draws.”
The trials will match patients with a treatment according to findings on imaging, such as hemorrhage, brain bruising or neuro-inflammation, as well as the presence of blood-based biomarkers.
There were approximately 2.8 million TBI-associated hospitalizations, visits to emergency departments and deaths in 2013, according to the U.S. Centers for Disease Control and Prevention. Although many patients recover spontaneously from TBIs – which include concussions, regarded as mild TBIs – memory, movement, sensations and emotions may be impacted in the long term.
Earlier this year, UCSF researchers reported links between TBI and dementia, and TBI and Parkinson’s disease.
Awareness of TBI has focused on athletes and those in the armed forces, noted Manley, who is also chief of neurosurgery at Zuckerberg San Francisco General Hospital and Trauma Center, and a member of the UCSF Weill Institute for Neurosciences. In fact, the condition is prevalent across all populations, due to falls and motor vehicle accidents, with the fastest-growing incidence among those over the age of 75.
“We are entering a new era of precision medicine in the research and treatment of TBI,” Manley said. “Using novel and developing tools in the fields of imaging, biomarkers and genomics, we are better able to diagnose patients and test treatments to relieve the substantial burden that patients carry for life.”
TRACK-TBI has built a network of 3,000 patients whose diagnoses cover the spectrum of mild-to-severe TBI, and developed a standardized approach to analyze imaging, clinical data, biospecimens and treatment outcomes across research sites. Additionally, its databases include what may be the world’s largest serial collection of brain scans and biospecimens of TBI patients.
The U.S. Department of Defense award will be administered by the Medical Technology Enterprise Consortium over a five-year period.
LINK: https://www.ucsf.edu/news/2018/10/412001/ucsf-led-consortium-receives-262m-develop-therapies-traumatic-brain-injury
$QRON
Recent QRON News
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2024 09:16:00 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM